Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 40 and 80 years old
- You have a family history of glaucoma (a relative has been diagnosed with glaucoma)
- You are willing to take part in the study
- You are willing to sign a consent form agreeing to participate
Who may not be able to join:
- You are not willing to sign the consent form to participate
- You have already been diagnosed with glaucoma or any other eye condition that requires regular eye check-ups or treatment
- You have a history of glaucoma that was present from birth or developed during childhood
- You have a history of a lazy eye (amblyopia) or a condition where the eyes do not point in the same direction (strabismus)
- You have a known eye condition that causes cloudiness in the eye, such as cataracts or clouding of the cornea, which could prevent clear photographs of the back of the eye from being taken
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marta Pazos, MD, PhD, Glaucoma Consultant - Head of Ophthalmic Surgery Department
Phone: +34932275400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic agreement between the AI software and the ophthalmic examination; Health-Related Quality of Life (HRQoL); Demographics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.